日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multifunctional Nanoscale Platform for the Study of T Cell Receptor Segregation

用于研究T细胞受体分离的多功能纳米平台

Esti Toledo ,Muhammed Iraqi ,Ashish Pandey ,Sivan Tzadka ,Guillaume Le Saux ,Angel Porgador ,Mark Schvartzman

NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs

NKp44衍生肽联合使用可增强靶向治疗药物的抗肿瘤功效

Muhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar, Baisali Bhattacharya, Muhammad Abu Ahmad, Avishay Edri, Laila C Roisman, Moshe Elkabets, Walid Shalata, Nir Peled, Angel Porgador

Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma

阻断PCNA/NKp44检查点以刺激NK细胞对多发性骨髓瘤的反应

Muhammed Iraqi ,Avishay Edri ,Yariv Greenshpan ,Oron Goldstein ,Noa Ofir ,Priyanka Bolel ,Muhammad Abu Ahmad ,Miri Zektser ,Kerry S Campbell ,Ory Rouvio ,Roi Gazit ,Angel Porgador

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)

晚期癌症患者(肺腺癌和恶性胸膜间皮瘤)对仑伐替尼和派姆单抗联合治疗的快速反应

Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, Vered Fuchs, Laila C Roisman, Ahron Yehonatan Cohen, Ismaell Massalha, Alexander Yakobson, Manu Prasad, Moshe Elkabets, Angel Porgador, Nir Peled

N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion

N-糖链介导埃博拉病毒GP1对配体与免疫受体的屏蔽以及免疫逃逸

Muhammed Iraqi ,Avishay Edri ,Yariv Greenshpan ,Kiran Kundu ,Priyanka Bolel ,Avishag Cahana ,Aner Ottolenghi ,Roi Gazit ,Leslie Lobel ,Alex Braiman ,Angel Porgador

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells

埃博拉糖蛋白调节自然杀伤细胞的功能

Avishay Edri, Avishai Shemesh, Muhammed Iraqi, Omri Matalon, Michael Brusilovsky, Uzi Hadad, Olga Radinsky, Orly Gershoni-Yahalom, John M Dye, Ofer Mandelboim, Mira Barda-Saad, Leslie Lobel, Angel Porgador